CHRONOS-3 (R/R)

CHRONOS-3 (R/R)

A Phase III, Randomized, Double-blind, Placebo-controlled Study Evaluating the Efficacy and Safety of Copanlisib in Combination With Rituximab in Patients With Relapsed Indolent B-cell Non-Hodgkin's Lymphoma (iNHL) (CHRONOS-3)


Study Treatments


Inclusion criteria


Exclusion criteria


Participating sites

Link